Home NDC 0024-5920 KEVZARA
Product NDC 0024-5920
11-digit product format 000245920
Labeler code 0024
Product ID 0024-5920_b1eeca31-be2b-4c68-a7c0-220256a2b906
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name sarilumab
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Sanofi-Aventis U.S. LLC
Application BLA761037
Marketing category BLA
Marketing start 2017-05-22
Substance SARILUMAB
Active strength 150 mg/1.14mL
Pharmacologic classes Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base KEVZARA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SARILUMAB 150 mg/1.14mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination NU90V55F8I Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 8 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1923333 Internal RxNorm lookup 1923338 Internal RxNorm lookup 1923345 Internal RxNorm lookup 1923347 Internal RxNorm lookup 2003755 Internal RxNorm lookup 2003757 Internal RxNorm lookup 2003766 Internal RxNorm lookup 2003767 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0024-5920-00 KEVZARA 1.14 mL in 1 SYRINGE INJECTION, SOLUTION 1.14 15 0024-5920-01 KEVZARA 2 in 1 PACKAGE INJECTION, SOLUTION 2 15 0024-5920-02 KEVZARA 2 in 1 PACKAGE INJECTION, SOLUTION 2 15 0024-5920-02 KEVZARA 1.14 mL in 1 SYRINGE INJECTION, SOLUTION 1.14 15
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0024-5920 KEVZARA (SARILUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] 14 Current NDC, Legacy NDC, 4 package rows 20250523_827bc01c-d379-4266-a18c-c7f904b76af3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join KEVZARA SARILUMAB Sanofi-Aventis U.S. LLC 827bc01c-d379-4266-a18c-c7f904b76af3 2026-02-27 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761037 ndc (product): 0024-5920
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761037 Kevzara sarilumab 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0024-5920-00 00024592000 1.14 mL in 1 SYRINGE 1.14 ml Historical 0024-5920-01 00024592001 2 SYRINGE in 1 PACKAGE (0024-5920-01) / 1.14 mL in 1 SYRINGE (0024-5920-00) 2 syringe 2018-04-13 0000-00-00 No No Current 0024-5920-02 00024592002 2 SYRINGE in 1 PACKAGE (0024-5920-02) / 1.14 mL in 1 SYRINGE 2 syringe 2018-04-13 0000-00-00 No No Current